Another week in the bank. Here are my picks for the top five stories of the week: Hospitals Adopt Drug Industry Sales Strategy. Hospitals are starting to sell themselves using ole’ pharma tactics! Plaintiffs Win Key Ruling On Preemption In Metoclopramide Mass Tort Litigation. A state trial judge in Philadelphia has denied generic drug manufacturers’ [...]
Tag Archives | Drugs
Agency Overrules FDA’s Recommendation That The Morning After Bill Be Available Without A Prescription
In a move that smacks of politics rather than safety, the Department of Health and Human Services overruled the FDA’s decision to make the “morning after pill” or Plan B available over the counter. The sign that this move is more political than safety related, the Secretary of DHHS issued a statement containing the following: [...]
Here We Go Again: Sanofi Denies Lantus Linked To Cancer
A $4 billion-a-year drug linked to cancer? A company denying it? Well, it’s the same ole’ thing as Sanofi denies that it’s drug used to treat diabetes (the insulin Lantus) is linked to cancer. A new study done by Swedish researchers looked at the medical records of 23,000 people in the southwest of the country [...]
No Generic Drug Preemption For “Dear Doctor” Letters
A Nevada State Court Judge ruled that plaintiffs can sue generic drug manufacturers despite the Supreme Court’s recent ruling protecting drug companies from lawsuits in PLIVA, Inc. v. Mensing
Welcome To The Bark
The Bark is the blog of Mark Sadaka. Mark is the founder of Law Offices of Sadaka Associates LLC, advocate and scientist.
Subscribe / Connect
Get Updates To The Bark In Your Mailbox By Signing Up Below.
